All
1.
Alterations of the genes involved in the PI3K and estrogen-receptor pathways influence outcome in human epidermal growth factor receptor 2-positive and hormone receptor-positive breast cancer patients treated with trastuzumab-containing neoadjuvant chemotherapy
Mamoru Takada, Toru Higuchi, Katsunori Tozuka, Hiroyuki Takei, Masayuki Haruta, Junko Watanabe, Fumio Kasai, Kenichi Inoue, Masafumi Kurosumi, Masaru Miyazaki, Aiko Sato-Otsubo, Seishi Ogawa, Yasuhiko Kaneko BMC Cancer 2013, 13 :241 (16 May 2013)
Abstract | Provisional PDF
| PubMed
2.
High CRP values predict poor survival in patients with penile cancer
Sandra Steffens, Andreas Al Ghazal, Julie Steinestel, Rieke Lehmann, Gerd Wegener, Thomas J Schnoeller, Marcus V Cronauer, Florian Jentzmik, Mark Schrader, Markus A Kuczyk, Andres J Schrader BMC Cancer 2013, 13 :223 (3 May 2013)
Abstract | Full text | PDF
| ePUB | PubMed
3.
Prognostic significance of peripheral monocyte count in patients with extranodal natural killer/T-cell lymphoma
Jia-Jia Huang, Ya-Jun Li, Yi Xia, Yu Wang, Wen-Xiao Wei, Ying-Jie Zhu, Tong-Yu Lin, Hui-Qiang Huang, Wen-Qi Jiang, Zhi-Ming Li BMC Cancer 2013, 13 :222 (3 May 2013)
Abstract | Full text | PDF
| ePUB | PubMed
4.
Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK population
Mererid Evans, Robert Newcombe, Alison Fiander, James Powell, Martin Rolles, Selvam Thavaraj, Max Robinson, Ned Powell BMC Cancer 2013, 13 :220 (1 May 2013)
Abstract | Full text | PDF
| ePUB | PubMed
5.
A comprehensive analysis of Aurora A; transcript levels are the most reliable in association with proliferation and prognosis in breast cancer
Satoko Yamamoto, Mutsuko Yamamoto-Ibusuki, Yutaka Yamamoto, Saori Fujiwara, Hirotaka Iwase BMC Cancer 2013, 13 :217 (30 April 2013)
Abstract | Provisional PDF
| PubMed
6.
MicroRNA profile of paclitaxel-resistant serous ovarian carcinoma based on formalin-fixed paraffin-embedded samples
Xiao Li, Yaer Lu, Yaxia Chen, Weiguo Lu, Xing Xie BMC Cancer 2013, 13 :216 (30 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
7.
Differential expression of histone deacetylases HDAC1, 2 and 3 in human breast cancer - overexpression of HDAC2 and HDAC3 is associated with clinicopathological indicators of disease progression
Berit Maria Müller, Lisa Jana, Atsuko Kasajima, Annika Lehmann, Judith Prinzler, Jan Budczies, Klaus-Jürgen Winzer, Manfred Dietel, Wilko Weichert, Carsten Denkert BMC Cancer 2013, 13 :215 (30 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
8.
Can selenium levels act as a marker of colorectal cancer risk?
Marcin R Lener, Satish Gupta, Rodney J Scott, Martin Tootsi, Maria Kulp, Mari-Liis Tammesoo, Anu Viitak, Anders Metspalu, Pablo Serrano-Fernández, Józef Kładny, Katarzyna Jaworska-Bieniek, Katarzyna Durda, Magdalena Muszyńska, Grzegorz Sukiennicki, Anna Jakubowska, Jan Lubiński BMC Cancer 2013, 13 :214 (29 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
9.
Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma
Chiharu Tabata, Eisuke Shibata, Rie Tabata, Shingo Kanemura, Koji Mikami, Yoshitaka Nogi, Eriko Masachika, Tomoyuki Nishizaki, Takashi Nakano BMC Cancer 2013, 13 :205 (24 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
10.
Circulating tumor cells in HER2-positive metastatic breast cancer patients: a valuable prognostic and predictive biomarker
Yi Liu, Qian Liu, Tao Wang, Li Bian, Shaohua Zhang, Haixu Hu, Sha Li, Zhiyuan Hu, Shikai Wu, Bing Liu, Zefei Jiang BMC Cancer 2013, 13 :202 (23 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
11.
Reduced mrna expression level of corticotropin-releasing hormone-binding protein is associated with aggressive human kidney cancer
Hossein Tezval, Faranaz Atschekzei, Inga Peters, Sandra Waalkes, Jörg Hennenlotter, Arnulf Stenzl, Jan U Becker, Axel S Merseburger, Markus A Kuczyk, Jürgen Serth BMC Cancer 2013, 13 :199 (22 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
12.
Differential expression of colon cancer associated transcript1 (CCAT1) along the colonic adenoma-carcinoma sequence
Bilal Alaiyan, Nadia Ilyayev, Alexander Stojadinovic, Mina Izadjoo, Marina Roistacher, Vera Pavlov, Victoria Tzivin, David Halle, Honguang Pan, Barry Trink, Ali O Gure, Aviram Nissan BMC Cancer 2013, 13 :196 (17 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
13.
High expression of ubiquitin-conjugating enzyme 2C (UBE2C) correlates with nasopharyngeal carcinoma progression
Zhihua Shen, Xiaofan Jiang, Chao Zeng, Shaojiang Zheng, Botao Luo, Yumei Zeng, Ranran Ding, Hanguo Jiang, Qiyi He, Junli Guo, Wei Jie BMC Cancer 2013, 13 :192 (15 April 2013)
Abstract | Full text | PDF
| PubMed
14.
Correlation of CD44v6 expression with ovarian cancer progression and recurrence
Jun Shi, Zhou Zhou, Wen Di, Ningli Li BMC Cancer 2013, 13 :182 (8 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
15.
Inverse expression of hyaluronidase 2 and hyaluronan synthases 1–3 is associated with reduced hyaluronan content in malignant cutaneous melanoma
Siiskonen Hanna, Poukka Mari, Tyynelä-Korhonen Kristiina, Sironen Reijo, Pasonen-Seppänen Sanna BMC Cancer 2013, 13 :181 (5 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
16.
Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer
Patrick C O¿Leary, Sarah Penny, Roisin T Dolan, Catherine M Kelly, Stephen F Madden, Elton Rexhepaj, Donal J Brennan, Amanda H McCann, Fredrik Pontén, Mathias Uhlén, Radoslaw Zagozdzon, Michael J Duffy, Malcolm R Kell, Karin Jirström, William M Gallagher BMC Cancer 2013, 13 :175 (2 April 2013)
Abstract | Provisional PDF
| PubMed
17.
Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Cooperative Oncology Group (HeCOG) phase III trials
George Fountzilas, Urania Dafni, Mattheos Bobos, Vassiliki Kotoula, Anna Batistatou, Ioannis Xanthakis, Christos Papadimitriou, Ioannis Kostopoulos, Triantafillia Koletsa, Eleftheria Tsolaki, Despina Televantou, Eleni Timotheadou, Angelos Koutras, George Klouvas, Epaminontas Samantas, Nikolaos Pisanidis, Charisios Karanikiotis, Ioanna Sfakianaki, Nicholas Pavlidis, Helen Gogas, Helena Linardou, Konstantine T Kalogeras, Dimitrios Pectasides, Meletios A Dimopoulos BMC Cancer 2013, 13 :163 (28 March 2013)
Abstract | Full text | PDF
| ePUB | PubMed
18.
A novel panel of biomarkers in distinction of small well-differentiated HCC from dysplastic nodules and outcome values
Guang-Zhi Jin, Hui Dong, Wen-Long Yu, Yan Li, Xin-Yuan Lu, Hua Yu, Zhi-Hong Xian, Wei Dong, Yin-Kun Liu, Wen-Ming Cong, Meng-Chao Wu BMC Cancer 2013, 13 :161 (27 March 2013)
Abstract | Full text | PDF
| PubMed
19.
53BP1 expression is a modifier of the prognostic value of lymph node ratio and CA 19–9 in pancreatic adenocarcinoma
Natalie L Ausborn, Tong Wang, Sabrina C Wentz, Mary Kay Washington, Nipun B Merchant, Zhiguo Zhao, Yu Shyr, Anuradha Bapsi Chakravarthy, Fen Xia BMC Cancer 2013, 13 :155 (26 March 2013)
Abstract | Full text | PDF
| ePUB | PubMed
20.
Type IV collagen stimulates pancreatic cancer cell proliferation, migration, and inhibits apoptosis through an autocrine loop
Daniel Öhlund, Oskar Franklin, Erik Lundberg, Christina Lundin, Malin Sund BMC Cancer 2013, 13 :154 (26 March 2013)
Abstract | Full text | PDF
| ePUB | PubMed
21.
HP1γ expression is elevated in prostate cancer and is superior to Gleason score as a predictor of biochemical recurrence after radical prostatectomy
Jon Slezak, Matthew Truong, Wei Huang, David Jarrard BMC Cancer 2013, 13 :148 (23 March 2013)
Abstract | Full text | PDF
| ePUB | PubMed
22.
Snail1 expression in colorectal cancer and its correlation with clinical and pathological parameters
Feride Kroepil, Georg Fluegen, Daniel Vallböhmer, Stephan E Baldus, Levent Dizdar, Andreas M Raffel, Dieter Hafner, Nikolas H Stoecklein, Wolfram T Knoefel BMC Cancer 2013, 13 :145 (22 March 2013)
Abstract | Full text | PDF
| ePUB | PubMed
23.
Wdr66 is a novel marker for risk stratification and involved in epithelial-mesenchymal transition of esophageal squamous cell carcinoma
Qing Wang, Chenming Ma, Wolfgang Kemmner BMC Cancer 2013, 13 :137 (21 March 2013)
Abstract | Full text | PDF
| ePUB | PubMed
24.
Progress risk assessment of oral premalignant lesions with saliva miRNA analysis
Ya Yang, Yue-xiu Li, Xi Yang, Long Jiang, Zuo-jun Zhou, Ya-qin Zhu BMC Cancer 2013, 13 :129 (19 March 2013)
Abstract | Full text | PDF
| ePUB | PubMed
25.
α B-crystallin stimulates VEGF secretion and tumor cell migration and correlates with enhanced distant metastasis in head and neck squamous cell carcinoma
Chantal van de Schootbrugge, Johan Bussink, Paul N Span, Fred CGJ Sweep, Reidar Grénman, Hanneke Stegeman, Ger JM Pruijn, Johannes HAM Kaanders, Wilbert C Boelens BMC Cancer 2013, 13 :128 (18 March 2013)
Abstract | Full text | PDF
| ePUB | PubMed
